Attributes of health; measurement of health; value of health;
value of life; value of avoiding risk of ill-health; utility measures of health-related quality of life; stated and revealed preference methods of measuring willingness to pay; conjoint analysis.
The EQ Valuation Technology (EQ-VT) protocol has been widely used in the valuation of EuroQol instruments, including in over 25 national EQ-5D-5L value sets and, in an adapted form, the valuation of EQ-5D-Y-3L. Adapted versions of it are also currently… Read More »The ‘wheelchair example’ – why it should be dropped from EQ-5D valuation tasks
Sometimes research gets left in a drawer. The virtual equivalent can happen to blog posts. In clearing out some old drafts, I found a blog post on capabilities that it seems I wrote in May 2014. I don’t remember what… Read More »Choices, capabilities, and unanswered questions
From time to time, a little puff of steam emerges from my Twitter feed as Paul Kind (one of the founding members of the EuroQol Group and a key figure in the development of the EQ-5D) objects to yet another… Read More »‘Preference-based measure’ is misleading – can we agree on something better?
As many of us who have had to review submitted journal articles, thesis defenses, grant applications, white papers, and even published literature know, providing feedback on something that is poorly conceived is much harder than providing feedback on something well… Read More »Are QALYs #ableist?
Why did I do it? I have evaluated lots of services and been involved in trials where I have asked people to collect EQ-5D data. During this time several people have complained to me about having to collect EQ-5D data… Read More »My quality-adjusted life year
Over at the CLAHRC West Midlands blog, Richard Lilford (my boss, I should hasten to add!) writes about the difficulties with the economic evaluation of IVF. The post notes that there are a number of issues that “are not generally… Read More »IVF and the evaluation of policies that don’t affect particular persons
We’ve seen a few editorials and commentaries popping up about the EQ-5D-5L recently, in Health Economics, PharmacoEconomics, and PharmacoEconomics again. All of these articles have – to varying extents – acknowledged the need for NICE to exercise caution in the… Read More »Bad reasons not to use the EQ-5D-5L
In this week’s round-up, I highlighted a recent paper in the journal Cambridge Quarterly of Healthcare Ethics. There are some interesting ideas presented regarding the challenge of decision-making at the individual patient level, and in particular a supposed trade-off between achieving… Read More »On the commensurability of efficiency
On the third Thursday of every month, we speak to a recent graduate about their thesis and their studies. This month’s guest is Dr Koonal Shah who has a PhD from the University of Sheffield. If you would like to suggest… Read More »Thesis Thursday: Koonal Shah
Today’s Journal Club Briefing comes from the Academic Unit of Health Economics at the University of Leeds. At their journal club on 2nd August 2017, they discussed Dolan and Kahneman’s 2008 article from The Economic Journal: ‘Interpretations of utility and… Read More »Journal Club Briefing: Dolan and Kahneman (2008)